AKBA icon

Akebia Therapeutics

132 hedge funds and large institutions have $470M invested in Akebia Therapeutics in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 53 increasing their positions, 33 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$391K
Puts
$185K
Net Calls
Net Calls Change

Top Buyers

1 +$8.42M
2 +$5.95M
3 +$5.31M
4
NHAS
Novo Holdings A/S
Denmark
+$5.02M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$4.26M

Top Sellers

1 -$5.81M
2 -$5.17M
3 -$4.86M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.31M
5
Two Sigma Investments
Two Sigma Investments
New York
-$3.04M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$792K
52
$783K
53
$779K
54
$768K
55
$764K
56
$720K
57
$664K
58
$644K
59
$642K
60
$629K
61
$612K
62
$606K
63
$592K
64
$588K
65
$562K
66
$541K
67
$516K
68
$507K
69
$477K
70
$462K
71
$448K
72
$424K
73
$410K
74
$387K
75
$370K